<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Investigation of the uptake and metabolism of drugs by organs such as the liver may allow assessment of specific aspects of organ function </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="28077">Rifampicin</z:chebi>, when orally administered, is transported into the hepatocyte from portal blood and thence passes, with its deacetylated metabolite, into the systemic circulation and into bile </plain></SENT>
<SENT sid="2" pm="."><plain>This paper reports an investigation of the pharmacokinetics of a sub-therapeutic oral dose of <z:chebi fb="0" ids="28077">rifampicin</z:chebi> in healthy subjects, in patients with <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> and in subjects with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The areas under the plasma concentration curves (AUC) in patients with <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> were significantly greater than in healthy subjects </plain></SENT>
<SENT sid="4" pm="."><plain>Subjects with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> had decreased AUCs compared with healthy subjects and were clearly distinguished from patients with <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="28077">Rifampicin</z:chebi> concentration in serum was measured by HPLC using a novel direct injection technique </plain></SENT>
</text></document>